Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leyang Wu

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Acta Pharmaceutica Sinica. B|October 10, 2022
Macrophage-mediated tumor-targeted delivery of engineered <i>Salmonella typhi</i> <i>murium</i> VNP20009 in anti-PD1 therapy against melanomaLeyang Wu, Lin Li, Shufeng Li, et al.
Journal of Hematology & Oncology|July 7, 2026
From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicineLiyuan Qiao, Leyang Wu, Yihan Xiao, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 18, 2024
Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis ImmunotherapyLeyang Wu, Liyuan Qiao, Shuhui Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 26, 2024
Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor ImmunityLeyang Wu, Lin Li, Liyuan Qiao, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 17, 2025
Correction to "Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy"Leyang Wu, Liyuan Qiao, Shuhui Zhang, et al.
Journal of the American Chemical Society|October 13, 2022
Combined Cellular Thermometry Reveals That <i>Salmonella typhimurium</i> Warms Macrophages by Inducing a Pyroptosis-like PhenotypeLeyang Wu, Feng Chen, Xiaoyao Chang, et al.
Iscience|December 9, 2025
A stable and antibiotic-free plasmid expression system for <i>Salmonella typhimurium</i> VNP20009 in tumor therapyChao Han, Jing Li, Xinyue Qiao, et al.
Trends in Biotechnology|October 31, 2025
Precision tumor immunotherapy via a dual-gated macrophage-bacterial activation platformLin Li, Leyang Wu, Liyuan Qiao, et al.
Cell Reports|January 30, 2026
Controlled pyroptosis of engineered macrophages enables biphasic antitumor via the release of oncolytic bacteria and inflammatory signalsLeyang Wu, Chenyang Li, Liyuan Qiao, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Acta Pharmaceutica Sinica. B|October 10, 2022
Macrophage-mediated tumor-targeted delivery of engineered <i>Salmonella typhi</i> <i>murium</i> VNP20009 in anti-PD1 therapy against melanomaLeyang Wu, Lin Li, Shufeng Li, et al.
Journal of Hematology & Oncology|July 7, 2026
From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicineLiyuan Qiao, Leyang Wu, Yihan Xiao, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 18, 2024
Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis ImmunotherapyLeyang Wu, Liyuan Qiao, Shuhui Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 26, 2024
Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor ImmunityLeyang Wu, Lin Li, Liyuan Qiao, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 17, 2025
Correction to "Dual-Engineered Macrophage-Microbe Encapsulation for Metastasis Immunotherapy"Leyang Wu, Liyuan Qiao, Shuhui Zhang, et al.
Journal of the American Chemical Society|October 13, 2022
Combined Cellular Thermometry Reveals That <i>Salmonella typhimurium</i> Warms Macrophages by Inducing a Pyroptosis-like PhenotypeLeyang Wu, Feng Chen, Xiaoyao Chang, et al.
Iscience|December 9, 2025
A stable and antibiotic-free plasmid expression system for <i>Salmonella typhimurium</i> VNP20009 in tumor therapyChao Han, Jing Li, Xinyue Qiao, et al.
Trends in Biotechnology|October 31, 2025
Precision tumor immunotherapy via a dual-gated macrophage-bacterial activation platformLin Li, Leyang Wu, Liyuan Qiao, et al.
Cell Reports|January 30, 2026
Controlled pyroptosis of engineered macrophages enables biphasic antitumor via the release of oncolytic bacteria and inflammatory signalsLeyang Wu, Chenyang Li, Liyuan Qiao, et al.
Pageof 2